Key points are not available for this paper at this time.
To compare the effectiveness of cellular tissue products (CTP) versus standard care in U.S. Medicare beneficiaries with diabetic lower extremity ulcers (DLEUs) or venous leg ulcers (VLUs).
Padula et al. (Tue,) studied this question.